Michael M. Babich

Michael M. Babich

Gastroenterology | Cardiology
1307 Federal Street
Pittsburgh, PA 15212

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications

Topology and adenocarcinoma cell localization dataset on the labyrinthin diapeutic biomarker.

Topology and adenocarcinoma cell localization dataset on the labyrinthin diapeutic biomarker.

Journal: BMC research notes
Published: April 25, 2023

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer.

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer.

Journal: Cancers
Published: November 30, 2022

Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen.

Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen.

Journal: Heliyon
Published: October 04, 2021

Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat Cancer.

Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat Cancer.

Journal: OncoTargets and therapy
Published: June 23, 2019
Showing 1-4 of 4

Last Updated: 09/26/2026